There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioSig Technologies (BSGM – Research Report) and Siemens Healthineers AG (SEMHF – Research Report) with bullish sentiments.
BioSig Technologies (BSGM)
In a report released today, Gregory Aurand from Noble Financial maintained a Buy rating on BioSig Technologies, with a price target of $4.00. The company’s shares closed last Wednesday at $0.63, close to its 52-week low of $0.55.
According to TipRanks.com, Aurand is ranked #7613 out of 7904 analysts.
BioSig Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $4.00.
Siemens Healthineers AG (SEMHF)
Berenberg Bank analyst Odysseas Manesiotis maintained a Buy rating on Siemens Healthineers AG today and set a price target of EUR75.00. The company’s shares closed last Tuesday at $50.10, close to its 52-week low of $45.93.
According to TipRanks.com, Manesiotis is ranked #7376 out of 7904 analysts.
Siemens Healthineers AG has an analyst consensus of Strong Buy, with a price target consensus of $71.84, representing a 44.4% upside. In a report released yesterday, J.P. Morgan also maintained a Buy rating on the stock with a EUR69.40 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BSGM:
- Colliers to invest in leading alternative investment manager
- U.S. Energy Corp. Announces East Texas Bolt-On Asset Acquisition
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
- Constellation Brands Reports First Quarter Fiscal 2023 Financial Results
- The Simply Good Foods Company Reports Fiscal Third Quarter 2022 Financial Results